Prise en charge thérapeutique des paragangliomes malins: revue de littérature à travers un cas illustratif by Leila Afani, Hassan Errihani, Ahmad Awada

Get full text

Rare Features of Dermatomyositis in a Patient with Ovarian Cancer by Lissandra Dal Lago, Frédéric Vandergheynst, Ahmad Awada, Thierry Pepersack

Get full text

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion by Christoph Zielinski, Ahmad Awada, Joseph Gligorov, Guy Jerusalem, Christian Singer

Get full text

Promising Immuno-Oncology Treatments Beyond the 2018 Nobel Prize by Luís Castelo-Branco, Inês Pires Silva, Helena Canhão, Ahmad Awada

Get full text

Cytokine Landscape in Central Nervous System Metastases by Julie Marin, Fabrice Journe, Ghanem E. Ghanem, Ahmad Awada, Nadège Kindt

Get full text

Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity by Michel Moreau, Ahmad Awada, Marianne Paesmans, Dan Engelman, Antonia Lepida, Yasmine Zaouak

Get full text

RTK Inhibitors in Melanoma: From Bench to Bedside by Malak Sabbah, Ahmad Najem, Mohammad Krayem, Ahmad Awada, Fabrice Journe, Ghanem E. Ghanem

Get full text

Case Report: Mammary and rectal metastases from an ovarian cancer: report of two cases and review of literature [v2; ref status: indexed, http://f1000r.es/4wh] by Mounia Amzerin, Camilo Garcia, Claudia Stanciu, Isabelle Veys, Ahmad Awada, Hassan Errihani, Andrea Gombos

Get full text

PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies by Anne Perdrix, Ahmad Najem, Sven Saussez, Ahmad Awada, Fabrice Journe, Ghanem Ghanem, Mohammad Krayem

Get full text

On the Analysis and Optimization of Fast Conditional Handover With Hand Blockage for Mobility by Subhyal Bin Iqbal, Salman Nadaf, Ahmad Awada, Umur Karabulut, Philipp Schulz, Gerhard P. Fettweis

Get full text

Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma by Ahmad Najem, Laura Soumoy, Malak Sabbah, Mohammad Krayem, Ahmad Awada, Fabrice Journe, Ghanem E. Ghanem

Get full text

Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies by Ahmad Najem, Mohammad Krayem, Serena Sabbah, Matilde Pesetti, Fabrice Journe, Ahmad Awada, Laurent Désaubry, Ghanem E. Ghanem

Get full text

Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment by Guilherme Nader-Marta, Chiara Molinelli, Véronique Debien, Diogo Martins-Branco, Philippe Aftimos, Evandro de Azambuja, Ahmad Awada

Get full text

Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value by Ahmad Najem, Jasper Wouters, Jasper Wouters, Mohammad Krayem, Florian Rambow, Florian Rambow, Malak Sabbah, François Sales, François Sales, Ahmad Awada, Ahmad Awada, Stein Aerts, Stein Aerts, Fabrice Journe, Fabrice Journe, Jean-Christophe Marine, Jean-Christophe Marine, Ghanem E. Ghanem

Get full text

Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer by Chris Twelves, Ahmad Awada, Javier Cortes, Louise Yelle, Galina Velikova, Martin S. Olivo, James Song, Corina E. Dutcus, Peter A. Kaufman

Get full text

Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer by Chris Twelves, Ahmad Awada, Javier Cortes, Louise Yelle, Galina Velikova, Martin S. Olivo, James Song, Corina E. Dutcus, Peter A. Kaufman

Get full text

The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma by Mohammad Krayem, Malak Sabbah, Ahmad Najem, An Wouters, Filip Lardon, Stephane Simon, François Sales, Fabrice Journe, Ahmad Awada, Ghanem E. Ghanem, Dirk Van Gestel

Get full text

Correction: Krayem et al. The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. <i>Cancers</i> 2019, <i>11</i>, 1093 by Mohammad Krayem, Malak Sabbah, Ahmad Najem, An Wouters, Filip Lardon, Stephane Simon, François Sales, Fabrice Journe, Ahmad Awada, Ghanem E. Ghanem, Dirk Van Gestel

Get full text

The benefit of co-targeting PARP-1 and c-Met on the efficacy of radiotherapy in wild type BRAF melanoma by Malak Sabbah, Ahmad Najem, Christophe Vanderkerkhove, Fabien Kert, Younes Jourani, Fabrice Journe, Ahmad Awada, Dirk Van Gestel, Ghanem E. Ghanem, Mohammad Krayem, Mohammad Krayem

Get full text

Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance by Pashalina Kehagias, Nadège Kindt, Mohammad Krayem, Ahmad Najem, Giulia Agostini, Elena Acedo Reina, Giacomo Bregni, Francesco Sclafani, Fabrice Journe, Ahmad Awada, Ghanem E. Ghanem, Alain Hendlisz

Get full text